Variant report
Variant | nsv963150 |
---|---|
Chromosome Location | chr2:56677451-56682246 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550511285 | chr2:56677460-56677461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570349504 | chr2:56677481-56677482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371905044 | chr2:56677539-56677540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192225072 | chr2:56677555-56677556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10174257 | chr2:56677556-56677557 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs542437257 | chr2:56677581-56677582 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10209137 | chr2:56677613-56677614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564771466 | chr2:56677624-56677625 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534858795 | chr2:56677628-56677629 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10209142 | chr2:56677632-56677633 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs59124481 | chr2:56677672-56677673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183903481 | chr2:56677715-56677716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149921035 | chr2:56677719-56677720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557685098 | chr2:56677767-56677768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188541656 | chr2:56677822-56677823 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs77070364 | chr2:56677831-56677832 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559852065 | chr2:56677832-56677833 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556754932 | chr2:56677834-56677835 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542001085 | chr2:56677842-56677843 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546930624 | chr2:56677847-56677848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531751841 | chr2:56677858-56677859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561875493 | chr2:56677957-56677958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530779291 | chr2:56678037-56678038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73942440 | chr2:56678056-56678057 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs564440127 | chr2:56678067-56678068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368783121 | chr2:56678077-56678078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181347372 | chr2:56678095-56678096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546207502 | chr2:56678096-56678097 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548357008 | chr2:56678126-56678127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560571515 | chr2:56678133-56678134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145250898 | chr2:56678145-56678146 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545657078 | chr2:56678153-56678154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548706387 | chr2:56678196-56678197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529403393 | chr2:56678239-56678240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548446424 | chr2:56678260-56678261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571885743 | chr2:56678329-56678330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs71414590 | chr2:56678342-56678343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34715521 | chr2:56678359-56678360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141297379 | chr2:56678360-56678361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577484531 | chr2:56678401-56678402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568245421 | chr2:56678411-56678412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539816029 | chr2:56678418-56678419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553405988 | chr2:56678463-56678464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573334906 | chr2:56678484-56678485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542334110 | chr2:56678534-56678535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184354245 | chr2:56678550-56678551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116212172 | chr2:56678556-56678557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143635440 | chr2:56678557-56678558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564195822 | chr2:56678560-56678561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533256158 | chr2:56678588-56678589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56674400-56678200 | Enhancers | Fetal Intestine Large | intestine |
2 | chr2:56675000-56677800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr2:56675000-56677800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr2:56675200-56678000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr2:56675400-56678200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr2:56675400-56679200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr2:56676000-56682800 | Weak transcription | Pancreas | Pancrea |
8 | chr2:56676600-56677800 | Enhancers | Fetal Kidney | kidney |
9 | chr2:56676800-56677800 | Enhancers | Fetal Intestine Small | intestine |
10 | chr2:56677000-56678000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr2:56677000-56678000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
12 | chr2:56677000-56678200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr2:56677000-56678200 | Enhancers | A549 | lung |
14 | chr2:56677200-56678000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr2:56677400-56677600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr2:56677600-56677800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr2:56678000-56678200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr2:56678000-56678200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
19 | chr2:56679200-56679400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |